InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,151.92
(
0.42%
)
Post# of 6723
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 826
Posts 119567
Boards Moderated 15
Alias Born 09/05/2002

DewDiligence

Member Level

Re: None

Thursday, 03/26/2020 5:33:37 PM

Thursday, March 26, 2020 5:33:37 PM

Post# of 6723
ABUS reports interim phase-1 data on AB-729 for HBV:

https://finance.yahoo.com/news/arbutus-announces-positive-preliminary-phase-200510591.html

AB-729 is an injected RNAi agent that targets HBsAg. The data reported today are from a single subcutaneous dose.

After 29 days, the mean reduction in HBsAg was: 0.2 logs in the 60mg cohort; and 0.8 logs in the 180mg cohort.

After 12 weeks, the mean reduction in HBsAg was: n/a in the 60mg cohort; and -1.0 logs in the 180mg cohort.

Whether HBsAg is the right target to be hitting is somewhat controversial—see, for instance, #msg-152274693

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent ABUS News
More ABUS News
InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news
Only $200 per official company press release!